Covid-19 Healthcare solutions

The pandemic of Covid-19 has shown the vulnerability of our healthcare systems when faced with viral infections without a known treatment. Understanding the transmission behavior of a virus such as SARS-CoV2 and fighting against its spread are crucial issues to which Bertin is responding with efficient solutions.

Bertin Instruments and Bertin Bioreagent are offering a complete workflow of solutions to help scientists in their studies on SARS-CoV-2 virus through laboratory equipment dedicated to collect, prepare & analyze samples, and kits & reagents for the detection of the virus.

THE AIR SAMPLERS CORIOLIS COLLECT CORONAVIRUS SARS-CoV-2

Early warning, detection, or identification of air contamination is crucial to combat a disease spread. Many diseases caused by biological agents are highly contagious, and during this time lag, infected people continue to spread the disease, increasing its reach. Additionally, difficulties in detecting biological agents is a major issue for homeland security. That is why Bertin Technologies developed a range of air samplers to collect all types of micro-organisms in the air for the control of airborne contamination.

Viruses are present in the air at a very diluted ratio therefore their detection is challenging. Bertin’s Coriolis air sampler is used in various environments by experts : hospitals, farms, and industrial settings, for the detection of different airborne viruses:  RSV (Respiratory Syncytial Virus) rotaviruses, influenza A and bacteriophages. Learn about those different applications in this white paper

Read more >>

DISCOVER OUR AIR SAMPLER SOLUTIONS >>

BERTIN BIOREAGENT IS NOW OFFERING KITS FOR THE STUDY OF SARS-CoV-2

Thanks to the newly signed distribution agreement between Cayman Chemical Company and GenScript Biotech Corporation, Bertin is now offering qRT-PCR kits for SARS-CoV-2 nucleic acid detection and ELISA kits for the detection of Spike S1-RBD IgG and IgM. Those products will help research community to tackle the challenge on COVID-19 therapeutics and diagnostics.

Read more >>

DISCOVER BERTIN BIOREAGENT >>

BERTIN TECHNOLOGIES IS MOBILIZED IN THE CREATION OF A QUICK DETECTION TEST OF SARS‑CoV‑2

Bertin Technologies, C4Diagnostics and Enalees work together on the development of a quick detection test of SARS-CoV-2 on the field, in less than 15minutes.

This test is a complementary tool to existing technologies in analysis plateforms. It provides a greater flexibility in tests logistics. In particular, when the access to such plateforms is difficult, sometimes impossible (confined or remote spaces), or when the results are needed urgently.

Its sales should start next June

Read the press release >>

Contact our experts >>

BERTIN BIOREAGENT: YOUR PARTNER TO STUDY THE ROLE OF ANGIOTENSIN II IN THE MECHANISM OF COVID-19

Recently, many studies regarding the Covid-19 pandemic focused on a potential involvement of Angiotensin II, a peptide hormone that increases blood pressure.

Bertin Bioreagent offers ELISA, a highly sensitive quantification kit (detection limit: 1pg/mL), to study and quantify Angiotensin II levels in plasma as well as culture supernatants in all mammalian species.

Read more >>

DISCOVER BERTIN BIOREAGENT >>

Bertin Medical Waste has a strong experience and expertise in treating biomedical waste on the site where it is produced. The Sterilwave technology grinds down and sterilizes all types of hospital waste that may potentially have been contaminated by the SARS-CoV-2 using microwave treatment and reduces significantly the risk of external contamination.

STERILWAVE SOLUTION ALLOWS ON-SITE TREATMENT OF WASTE CONTAMINATED BY THE CORONAVIRUS

These ultra-compact, innovative systems with proven efficiency in terms of viral inactivation make it possible to treat biomedical waste that has potentially been contaminated by the coronavirus (2019-nCoV) directly on site and consequently eliminate all risk of contamination outside the hospital. Thanks to Sterilwave solutions, the dangerous waste generated by hospitals is no longer taken by truck from the hospital to distant treatment sites, which significantly limits the risk of contagion. […]

Read more >>

DISCOVER OUR MEDICAL WASTE SOLUTIONS >>

HOSPITAL WASTE INFECTED WITH COVID-19 CAN BE TRIVIALIZED BY STERILWAVE

The Coronavirus pandemic increased the volume of biomedical waste by 3 to 5, creating a risk of saturation of collection solutions and the urgent need to integrate in-situ treatment systems. Considered as biomedical waste, SARS-CoV and MERS-CoV coronaviruses are classified in category 3, and are inactivated according to the disinfection parameters of the devices approved according to the NF X 30 503-1 standard: February 2016 (modification of the appearance of the waste and thermal treatment at a temperature greater than or equal to 100°C). Approved according to this standard, the Sterilwave solution has demonstrated its operational capacities for the treatment of COVID-19 infected biomedical waste in Wuhan hospitals in China.

Read more >>

DISCOVER OUR MEDICAL WASTE SOLUTIONS >>